Although the selective basis of these lesions remains unclear, genome-wide association studies in chronic lymphocytic leukaemia [58] and lymphoma [59] have identified germline variants in HLA-DRB5 influencing disease risk. This evidence concerns the gene HLA-DRB5 and lymphoma.